Sign in

CIK 0002020932 · Non-accelerated filer<br>Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
other
Phone
32 3 302 35 30
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 6-K Event Report of Foreign Issuer
  3. 20-F Report Annual and Transition Report of Foreign Private Issuers
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 6-K Event Report of Foreign Issuer
  19. SCHEDULE 13D Stake Beneficial Ownership Report
  20. 6-K Event Report of Foreign Issuer

Page 2 of 3 · 49 filings